Peiqing Liu Selected Research

Histone Methyltransferases

4/2022	Nuclear TIGAR mediates an epigenetic and metabolic autoregulatory loop via NRF2 in cancer therapeutic resistance.
2/2020	S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peiqing Liu Research Topics

Disease

36	Fibrosis (Cirrhosis) 04/2024 - 04/2007
34	Hypertrophy 04/2024 - 10/2008
32	Cardiomegaly (Heart Hypertrophy) 04/2024 - 05/2007
25	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 12/2006
24	Neoplasms (Cancer) 04/2024 - 01/2012
19	Inflammation (Inflammations) 03/2024 - 01/2011
15	Atherosclerosis 02/2020 - 02/2010
11	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 03/2009
9	Alzheimer Disease (Alzheimer's Disease) 12/2014 - 08/2008
7	Heart Failure 10/2021 - 02/2014
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2024 - 01/2019
6	Myocardial Infarction 03/2024 - 10/2012
6	Adenoviridae Infections (Adenovirus Infections) 07/2018 - 09/2016
5	Cardiotoxicity 03/2021 - 01/2019
4	Neoplasm Metastasis (Metastasis) 02/2024 - 11/2016
4	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 11/2016
4	Cardiomyopathies (Cardiomyopathy) 12/2023 - 01/2019
4	Infections 12/2023 - 04/2018
4	Rheumatoid Arthritis 12/2017 - 06/2009
4	Atherosclerotic Plaque (Atheroma) 12/2015 - 11/2011
3	Liver Neoplasms (Liver Cancer) 02/2024 - 11/2018
3	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2021
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022 - 02/2009
3	Breast Neoplasms (Breast Cancer) 02/2020 - 01/2014
3	Hypertension (High Blood Pressure) 01/2019 - 05/2007
3	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2019 - 01/2016
3	Arthritis (Polyarthritis) 01/2017 - 02/2013
2	Liver Diseases (Liver Disease) 01/2024 - 01/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2024 - 01/2018
2	Pneumonia (Pneumonitis) 01/2023 - 12/2020
2	Acute Lung Injury 01/2022 - 12/2020
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2022
2	Hypoxia (Hypoxemia) 01/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2024 - 08/2008
14	Isoproterenol (Isoprenaline)FDA LinkGeneric 04/2024 - 01/2014
14	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2011
13	cryptotanshinoneIBA 12/2023 - 03/2009
13	Angiotensin IIIBA 01/2018 - 05/2007
12	Fibronectins (Fibronectin)IBA 04/2024 - 12/2006
10	Biomarkers (Surrogate Marker)IBA 03/2024 - 12/2014
9	Messenger RNA (mRNA)IBA 01/2022 - 02/2012
8	tanshinoneIBA 07/2014 - 11/2011
7	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 01/2019
7	CytokinesIBA 12/2020 - 06/2009
7	ApolipoproteinsIBA 02/2020 - 11/2011
7	Transcription Factors (Transcription Factor)IBA 01/2018 - 03/2009
6	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2022 - 03/2015
6	CateninsIBA 01/2022 - 01/2011
6	Sirtuin 1IBA 01/2020 - 01/2013
6	Advanced Glycation End ProductsIBA 01/2018 - 12/2013
6	sphingosine kinaseIBA 10/2017 - 10/2010
6	BerberineIBA 01/2016 - 01/2011
6	oxidized low density lipoproteinIBA 12/2015 - 10/2010
5	AntioxidantsIBA 09/2023 - 01/2012
5	Sirtuin 3IBA 01/2023 - 10/2016
5	EnzymesIBA 01/2021 - 07/2015
5	LipidsIBA 02/2020 - 07/2014
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2014
5	NF-kappa B (NF-kB)IBA 01/2020 - 10/2012
5	Small Interfering RNA (siRNA)IBA 07/2018 - 01/2011
5	CholesterolIBA 12/2014 - 02/2010
4	MicroRNAs (MicroRNA)IBA 01/2024 - 10/2019
4	LipopolysaccharidesIBA 09/2023 - 01/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2014
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 09/2016
4	Butyryl-CoA Dehydrogenase (Short-Chain Acyl-CoA Dehydrogenase)IBA 01/2020 - 07/2015
4	Extracellular Matrix ProteinsIBA 01/2019 - 12/2011
4	Atrial Natriuretic Factor (ANF)IBA 12/2018 - 02/2014
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2018 - 01/2016
4	Apolipoproteins E (ApoE)IBA 12/2015 - 11/2011
4	Endothelin-1 (Endothelin 1)IBA 02/2014 - 10/2008
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2024 - 04/2022
3	CollagenIBA 02/2024 - 01/2013
3	CalciumIBA 01/2024 - 05/2014
3	Sorting NexinsIBA 12/2023 - 12/2017
3	Phosphotransferases (Kinase)IBA 12/2023 - 01/2017
3	SmokeIBA 09/2023 - 01/2023
3	Connexin 43 (Connexin43)IBA 01/2021 - 05/2013
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020 - 05/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 12/2013
3	Casein Kinase II (Casein Kinase 2)IBA 01/2018 - 01/2016
3	polydatinIBA 01/2017 - 10/2012
3	Therapeutic UsesIBA 01/2017 - 02/2014
3	Collagen Type II (Type II Collagen)IBA 01/2017 - 02/2013
3	SirtuinsIBA 09/2016 - 01/2016
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2016 - 10/2010
3	Sphingosine-1-Phosphate ReceptorsIBA 01/2016 - 05/2012
3	PPAR alphaIBA 05/2013 - 07/2007
3	Amyloid (Amyloid Fibrils)IBA 03/2012 - 08/2008
2	Matrix Metalloproteinases (MMPs)IBA 12/2023 - 11/2016
2	Autophagy-Related Protein-1 HomologIBA 12/2023 - 01/2019
2	Carrier Proteins (Binding Protein)IBA 12/2023 - 01/2019
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023 - 01/2019
2	Gefitinib (Iressa)FDA Link 01/2023 - 01/2021
2	Histone MethyltransferasesIBA 04/2022 - 02/2020
2	Sirolimus (Rapamycin)FDA Link 02/2022 - 01/2014
2	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2022 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 10/2012

Therapy/Procedure

20	Therapeutics 04/2024 - 05/2009
6	Drug Therapy (Chemotherapy) 04/2024 - 07/2019